Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis.
暂无分享，去创建一个
X. Mariette | J. Soria | C. Robert | O. Lambotte | A. Mékinian | C. Mateus | S. Champiat | A. Marabelle | R. Belkhir | O. Fain | J. Michot | B. Lioger | T. Szwebel | L. Coutte | S. Laghouati | A. Voisin | C. Luxembourger | S. Le Burel | L. Dunogeant